{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:31:01Z","timestamp":1760056261998,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["1.41"],"award-info":[{"award-number":["1.41"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jpba.2020.113783","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T11:06:10Z","timestamp":1605956770000},"page":"113783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The solution and solid-state degradation study followed by identification of tedizolid related compounds in medicinal product by high performance liquid chromatography with diode array and tandem mass spectrometry detection"],"prefix":"10.1016","volume":"194","author":[{"given":"Katarzyna","family":"Michalska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weronika","family":"Widy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Bus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Bocian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Tyski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113783_bib0005","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1128\/AAC.00663-10","article-title":"Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations","volume":"54","author":"Locke","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2020.113783_bib0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bmc.2012.11.036","article-title":"Recent development of potent analogues of oxazolidinone antibacterial agents","volume":"21","author":"Michalska","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2020.113783_bib0015","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.xphs.2020.01.028","article-title":"A novel systematic approach for selection of prodrugs designed to improve oral absorption","volume":"109","author":"Shimizu","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2020.113783_bib0020","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1124\/dmd.113.056697","article-title":"Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphate","volume":"42","author":"Ong","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2020.113783_bib0025","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ejmech.2011.01.014","article-title":"Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent","volume":"46","author":"Im","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpba.2020.113783_bib0030","unstructured":"Available at https:\/\/www.drugbank.ca\/drugs\/DB14569. Accessed February 19, 2020."},{"key":"10.1016\/j.jpba.2020.113783_bib0035","unstructured":"Available at https:\/\/www.drugbank.ca\/drugs\/DB09042. Accessed February 19, 2020."},{"key":"10.1016\/j.jpba.2020.113783_bib0040","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0731-7085(02)00047-X","article-title":"Development of validated stability-indicating assay methods-critical review","volume":"28","author":"Bakshi","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113783_bib0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jpba.2017.03.006","article-title":"Identification of forced degradation products of tedizolid phosphate by liquid chromatography\/electrospray ionization tandem mass spectrometry","volume":"139","author":"Lei","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113783_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2019.125111","article-title":"Solar-mediated degradation of linezolid and tedizolid under simulated environmental conditions: kinetics, transformation and toxicity","volume":"241","author":"Timm","year":"2020","journal-title":"Chemosphere"},{"key":"10.1016\/j.jpba.2020.113783_bib0055","series-title":"Pharmaceutical Stress Testing: Predicting Drug Degradation, (Drugs and the Pharmaceutical Sciences Book 210)","first-page":"10","article-title":"Stress testing: a predictive tool","author":"Baertschi","year":"2011"},{"key":"10.1016\/j.jpba.2020.113783_bib0060","first-page":"48","article-title":"Guidance and best practices for conducting forced degradation studies","volume":"26","author":"Reynolds","year":"2002","journal-title":"Pharm. Tech."},{"year":"2007","series-title":"Stability of Drugs and Dosage Forms","author":"Yoshioka","key":"10.1016\/j.jpba.2020.113783_bib0065"},{"year":"2005","series-title":"Validation of Analytical Procedures: Text and Methodology Q2(R1)","key":"10.1016\/j.jpba.2020.113783_bib0070"},{"key":"10.1016\/j.jpba.2020.113783_bib0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.surfrep.2008.10.001","article-title":"TiO2 photocatalisis and related surface phenomena","volume":"63","author":"Fujishima","year":"2008","journal-title":"Surf. Sci. Reports"},{"key":"10.1016\/j.jpba.2020.113783_bib0080","unstructured":"K. Reichenbacher, R.J. Duguid, J.A. Ware, D. Phillipson. Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyloxazoldin-2-one dhydrogen phosphate, U. S. Pat. Appl. Publ. (2013) US 2013\/0310343 A1."},{"key":"10.1016\/j.jpba.2020.113783_bib0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejps.2018.01.013","article-title":"Imitation of phase I metabolism reactions of MAO-A inhibitors by titanium dioxide photocatalysis","volume":"114","author":"Gawlik","year":"2018","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520316691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520316691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:09:35Z","timestamp":1760000975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708520316691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":17,"alternative-id":["S0731708520316691"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113783","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The solution and solid-state degradation study followed by identification of tedizolid related compounds in medicinal product by high performance liquid chromatography with diode array and tandem mass spectrometry detection","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113783"}}